###begin article-title 0
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BORIS</italic>
###xml 82 90 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2/H19</italic>
###xml 68 76 <span type="species:ncbi:9606">Patients</span>
No Evidence for Mutations of CTCFL/BORIS in Silver-Russell Syndrome Patients with IGF2/H19 Imprinting Control Region 1 Hypomethylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: JBL PS. Performed the experiments: JBL PS. Analyzed the data: JBL PS. Contributed reagents/materials/analysis tools: AB. Wrote the paper: JBL PS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2/H19</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 506 512 <span type="species:ncbi:10090">murine</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
Silver-Russell syndrome (SRS) is a genetically and clinically heterogeneous disease. Although no protein coding gene defects have been reported in SRS patients, approximately 50% of SRS patients carry epimutations (hypomethylation) at the IGF2/H19 imprinting control region 1 (ICR1). Proper methylation at ICR1 is crucial for the imprinted expression of IGF2, a fetal growth factor. CTCFL, a testis-specific protein, has recently been proposed to play a role in the establishment of DNA methylation at the murine equivalent of ICR1. A screen was undertaken to assess whether CTCFL is mutated in SRS patients with hypomethylation, to explore a link between the observed epimutations and a genetic cause of the disease.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 324 332 324 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 496 505 496 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 652 660 652 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
DNA was obtained from 36 SRS patients with hypomethylation at ICR1. All CTCFL coding exons were sequenced and analyzed for duplications/deletions using both multiplex ligation-dependent probe amplification, with a custom CTCFL probe set, and genomic qPCR. Novel SNP alleles were analyzed for potential differential splicing in vitro utilizing a splicing assay. Neither mutations of CTCFL nor duplications/deletions were observed. Five novel SNPs were identified and have been submitted to dbSNP. In silico splice prediction suggested one novel SNP, IVS2-66A>C, activated a cryptic splice site, resulting in aberrant splicing and premature termination. In vitro splicing assays did not confirm predicted aberrant splicing.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
As no mutations were detected at CTCFL in the patients examined, we conclude that genetic alterations of CTCFL are not responsible for the SRS hypomethylation. We suggest that analysis of other genes involved in the establishment of DNA methylation at imprinted genes, such as DNMT3A and DNMT3L, may provide insight into the genetic cause of hypomethylation in SRS patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-AbuAmero1">[1]</xref>
###xml 452 455 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-AbuAmero1">[1]</xref>
###xml 520 528 508 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2/H19</italic>
###xml 653 656 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-AbuAmero1">[1]</xref>
###xml 658 661 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Gicquel1">[2]</xref>
###xml 771 774 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bartholdi1">[3]</xref>
###xml 776 779 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bruce1">[4]</xref>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
Silver-Russell syndrome (SRS) is a rare and genetically heterogeneous disease (OMIM: 180860). Diagnosis of SRS includes: low birth weight and height, poor postnatal growth, skeletal asymmetry, triangular facial features and distinct head shape [1]. The etiology of the disease remains elusive as no protein coding gene mutations have been identified, although maternal uniparental disomy of chromosome 7 is observed in approximately10% of SRS patients [1]. More recently, however, an epimutation, hypomethylation of the IGF2/H19 imprinting control region 1 (ICR1) at 11p15, was observed in SRS patients and is now reported in approximately 50% of cases [1], [2]. Moreover, the extent of hypomethylation at ICR1 has recently been correlated to the severity of the disease [3], [4].
###end p 9
###begin p 10
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bartolomei1">[5]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Dechiara1">[6]</xref>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bushey1">[7]</xref>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Hark1">[8]</xref>
###xml 595 598 595 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Schoenherr1">[9]</xref>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 689 693 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 833 841 <span type="species:ncbi:9606">patients</span>
###xml 1063 1071 <span type="species:ncbi:9606">patients</span>
Methylation of the paternal ICR1 is crucial for imprinted expression of the two adjacent genes, IGF2 and H19. IGF2 codes for a fetal growth factor and is expressed uniquely from the paternal allele, while H19, a non-coding RNA, is expressed solely from the maternal allele [5], [6]. ICR1 is unmethylated on the maternal allele which allows binding by the insulator protein CTCF. CTCF blocks enhancer access to the IGF2 promoter, resulting in the silencing of IGF2 on the maternal allele [7]. However, methylation of the paternal ICR1 abrogates CTCF binding and IGF2 expression is activated [8], [9]. Diminished IGF2 expression, through ICR1 hypomethylation and subsequent CTCF binding and IGF2 enhancer blocking on the paternal allele, is thought to be responsible for the low birth weight and poor post-natal growth observed in SRS patients. Therefore, the ICR1 hypomethylation epimutation provides the strongest insight into the genetic cause of SRS and suggests that gene products involved in the establishment of DNA methylation at ICR1 may be mutated in SRS patients with hypomethylation.
###end p 10
###begin p 11
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Jelinic1">[10]</xref>
###xml 167 168 167 168 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</underline>
###xml 175 176 175 176 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</underline>
###xml 182 183 182 183 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 195 196 195 196 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 205 206 205 206 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Loukinov1">[11]</xref>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Loukinov1">[11]</xref>
###xml 689 697 689 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2/H19</italic>
###xml 703 710 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 967 974 967 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1103 1107 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Hata1">[12]</xref>
###xml 1108 1112 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Suetake1">[14]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Jelinic1">[10]</xref>
###xml 1250 1258 1250 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2/H19</italic>
###xml 1391 1398 1391 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1454 1462 1454 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2/H19</italic>
###xml 1602 1606 1602 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Zhao1">[15]</xref>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 658 664 <span type="species:ncbi:10090">murine</span>
###xml 931 938 <span type="species:ncbi:8355">Xenopus</span>
###xml 1156 1162 <span type="species:ncbi:10090">murine</span>
A mechanism for the establishment of DNA methylation at murine imprinted genes has recently been proposed involving the protein CTCFL/BORIS [10]. CTCF-like (CTCFL) or Brother Of the Regulator of Imprinted Sites (BORIS), hereafter called CTCFL, and the ubiquitously expressed CTCF are closely related by 79% similarity among the 11 zinc fingers they both contain [11]. However, CTCFL is uniquely expressed in the testis and shares no significant similarity in either the N- or C-termini to CTCF, suggesting that the two proteins perform different functions, although they most likely bind similar DNA sites [11]. Our laboratory has shown that CTCFL binds the murine equivalent of ICR1, the Igf2/H19 ICR, in vivo and interacts with the arginine methyltransferase PRMT7 and histones H1, H2A and H3. PRMT7 methylates histones H2A and H4 and CTCFL stimulates PRMT7-mediated histone methylation. Additionally, when CTCFL is expressed in Xenopus oocytes, with PRMT7 and the de novo DNA methyltransferases 3A, 3B and L (DNMT3A, B, L), which are essential for the establishment of methylation at imprinted genes [12]-[14], CpG dinucleotides of a plasmid containing murine ICR1 are methylated [10]. The current model contends that CTCFL specifically binds the Igf2/H19 ICR, recruits PRMT7, which then methylates nearby histones. This histone methylation can then serve as a recruitment signal for the de novo DNA methyltransferases which methylate the CpGs of the Igf2/H19 ICR. Recently, DNMT3A recruitment mediated by PRMT5 histone arginine methylation has been demonstrated, consistent with the proposed model [15].
###end p 11
###begin p 12
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igf2/H19</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 660 669 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 327 335 <span type="species:ncbi:9606">patients</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
Based on observations of hypomethylation at ICR1 in SRS patients and the proposed role of CTCFL in directing DNA methylation at the Igf2/H19 ICR, we hypothesized that SRS patients with hypomethylation at ICR1 could potentially harbor mutations in CTCFL, which would provide a genetic link to the epimutations observed in these patients. To test this hypothesis, 36 SRS patients with hypomethylation at ICR1 were screened for mutations in CTCFL. Additionally, the SRS patients were screened for exonic duplications/deletions using multiplex ligation-dependent probe amplification (MLPA) and qPCR. Lastly, a novel SNP revealed by CTCFL sequencing, and predicted in silico to activate a cryptic splice site, was tested for possible alternative splicing.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Sequence analysis
###end title 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g001">Figure 1A</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Loukinov1">[11]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Renaud1">[16]</xref>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 315 324 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g001">Figure 1A</xref>
###xml 436 443 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006631-t001">Table 1</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 556 569 556 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g001">Figure 1A, 1B</xref>
###xml 683 690 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006631-t002">Table 2</xref>
###xml 738 745 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006631-t002">Table 2</xref>
###xml 908 917 908 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g001">Figure 1B</xref>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 546 554 <span type="species:ncbi:9606">patients</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
###xml 807 815 <span type="species:ncbi:9606">patients</span>
###xml 899 906 <span type="species:ncbi:9606">patient</span>
CTCFL consists of 10 coding exons and 3 alternative first exons, which will be denoted here as the 5'UTR (Figure 1A) [11], [16]. All coding exons and the 5'UTR of CTCFL were sequenced in 36 SRS patients with hypomethylation at ICR1. Sequencing revealed SNPs present in dbSNP and included 5 polymorphic HapMap SNPs (Figure 1A). The HapMap SNPs allele frequencies did not significantly differ between SRS patients and the CEU population (Table 1). Five novel SNPs (not listed in either dbSNP or ABI SNP databases) were found in CTCFL among the SRS patients (Figure 1A, 1B), but the frequency of the observed SNPs did not significantly differ between the patients and healthy controls (Table 2). All novel SNPs have been deposited in dbSNP (Table 2). No nonsense or missense mutations were found in any of the patients, but one heterozygous silent mutation (1562A>G; K>K) was observed in exon 9 of one patient (Figure 1B).
###end p 15
###begin title 16
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
Distribution of polymorphic HapMap and novel SNPs within CTCFL.
###end title 16
###begin p 17
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 116 123 <span type="species:ncbi:9606">patient</span>
A) CTCFL gene structure showing relative positions of exons (solid boxes) and 5'UTR (dashed box). Sequencing of SRS patient DNAs led to the detection of novel SNPs (red dashes) and polymorphic HapMap SNPs (green dashes). B) Representative chromatograms of novel SNPs in comparison to wild-type sequence.
###end p 17
###begin title 18
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Polymorphic HapMap SNPs at CTCFL in SRS patients and CEU population.
###end title 18
###begin title 19
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Novel SNPs and frequencies in SRS patients and healthy controls at CTCFL.
###end title 19
###begin title 20
Exon duplication/deletion analysis
###end title 20
###begin p 21
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 160 168 160 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006631.s002">Table S2</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 371 380 371 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g002">Figure 2A</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 558 567 558 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g002">Figure 2B</xref>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 758 767 758 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g002">Figure 2B</xref>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 895 904 895 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g002">Figure 2B</xref>
###xml 933 938 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 427 435 <span type="species:ncbi:9606">patients</span>
###xml 498 506 <span type="species:ncbi:9606">patients</span>
###xml 679 686 <span type="species:ncbi:9606">patient</span>
###xml 731 739 <span type="species:ncbi:9606">patients</span>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
###xml 963 971 <span type="species:ncbi:9606">patients</span>
CTCFL was also screened for exonic deletions or duplications in these same patients using MLPA. Custom oligonucleotide MLPA probes were designed for each exon (Table S2). Twenty-one patients were screened at exons 2-11 and normalized by comparison to 7 healthy controls. Two SRS patients had a normalized value of 0.6 for exon 9 of CTCFL, suggesting a possible deletion (Figure 2A). To further examine exon 9 deletion in these patients, genomic qPCR was performed. CTCFL exon 9 was amplified in 27 patients and compared to levels of a diploid control, TP53 (Figure 2B). Also, as a second control, qPCR was performed on the X chromosome gene STS which is single copy in males. No patient had a quantity of exon 9 as low as the male patients at the STS locus (Figure 2B). Moreover, the copy number of CTCFL exon 9 for patients with the possible deletion was not significantly different from TP53 (Figure 2B), suggesting that exon 9 of CTCFL is not deleted in these patients.
###end p 21
###begin title 22
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
CTCFL exon duplication/deletion analysis in SRS patients.
###end title 22
###begin p 23
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 299 300 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 39 46 <span type="species:ncbi:9606">patient</span>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 564 572 <span type="species:ncbi:9606">patients</span>
A) MLPA analysis of CTCFL exons in SRS patient DNA. Connected symbols represent individual patients. Values obtained relative to control samples are presented. B) Copy number analysis of CTCFL exon 9 by genomic qPCR. Each point represents the mean Ct for the given reaction, normalized by the mean Ct obtained for TP53 (autosomal, two copies) from the same sample. All reactions were performed in quadruplicate and error bars represent standard error from the mean. All samples use FC (female control, non-SRS) as the reference sample. Numbers 19-213 refer to SRS patients and MC represents the male control (non-SRS).
###end p 23
###begin p 24
###xml 109 118 109 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g002">Figure 2A</xref>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g003">Figure 3</xref>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
MLPA also indicated a possible duplication of exon 5 in two patients with normalized ratios at or above 1.4 (Figure 2A). Extensive PCR analysis of exon 5 and the surrounding genomic region did not provide supporting evidence for exon 5 duplication (Figure 3).
###end p 24
###begin title 25
PCR analysis of exon 5 duplication.
###end title 25
###begin p 26
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006631.s004">Table S4</xref>
###xml 50 57 <span type="species:ncbi:9606">patient</span>
###xml 265 272 <span type="species:ncbi:9606">patient</span>
MLPA analysis suggested exon 5 duplication in SRS patient 162. Ten separate PCR reactions were performed to analyze exon 5 and adjacent genomic regions for evidence of duplication (scheme shown on top). PCR products from the respective reactions are shown for both patient 162 (left lane) and control (right lane) DNA. The sequences of primers used are given in Table S4.
###end p 26
###begin title 27
Splicing analysis
###end title 27
###begin p 28
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In silico</italic>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g004">Figure 4A</xref>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Jelinic1">[10]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Loukinov1">[11]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Singh1">[17]</xref>
###xml 962 967 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 1324 1333 1324 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g004">Figure 4B</xref>
###xml 1489 1498 1489 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006631-g004">Figure 4B</xref>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
As four of the five novel SNPs were observed in introns, analysis was undertaken to determine if these novel SNPs could affect splicing of CTCFL. In silico prediction of splicing using sequence from both the wild-type and novel SNPs was performed using two online tools, Flybase Splice Site Predictor and ESE Finder. All novel SNPs were tested, but only one SNP, IVS2-66A>C, was predicted by both programs to activate an alternative 3' splice site four nucleotides downstream from the SNP itself and to consequently add 61 bps to exon 3 resulting in a frame-shift and premature termination (Figure 4A). Testis samples from the SRS patients, where CTCFL is uniquely expressed, were not available [10], [11]. We therefore analyzed splicing among IVS2-66A>C and other nearby SNPs using a minigene splicing assay [17]. Total RNA was extracted from 293T cells transfected with a minigene plasmid (pRHCglo E2-5) containing the genomic region encompassing exons 2-5 of CTCFL with alleles carrying either the wild-type or variant SNP at IVS2-66. As other SNPs are located in the genomic region contained in pRHCglo E2-5, these were also tested for possible differential splicing. These SNPs included: two HapMap SNPs (rs6070128 and rs6025606), one other novel SNP (IVS2+55G>A) and a previously observed non-HapMap SNP (rs11699220) (Figure 4B). After specific reverse transcription and PCR of the spliced minigene transcript, no differences in splicing were observed for any of the alleles tested (Figure 4B).
###end p 28
###begin title 29
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
Splicing analysis of CTCFL exons 2 and 3.
###end title 29
###begin p 30
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 1031 1038 <span type="species:ncbi:9606">patient</span>
A) Expanded view of CTCFL exons 2-5 with sequence upstream of exon 3 with the location of SNPs indicated. The sequences and scores are outputs from the FlyBase Splice Prediction program. Higher scores indicate better alignment of the sequence to known splice sites. Arrows mark the nucleotide position changed by IVS2-66A>C and the score at the cryptic splice site increases from 0.66 to 0.94 with the single nucleotide substitution. Also shown is the wild-type CTCFL splicing according to the demarcated exon/intron junctions. Splicing for the IVS2-66A>C substitution is predicted to splice exon 2 to a cryptic splice site 61 bp upstream of the wild-type 5'exon 3 splice site (shown on bottom with the associated FlyBase score). Mis-splicing predicts a frame shift and premature termination in exon 3. B) The genomic region cloned into pRHCglo is shown and the relative positions of the SNPs analyzed are denoted alpha-epsilon. The table shows the haplotypes for each minigene cloned into pRHCglo which were derived from both SRS patient and control DNA. Each pRHCglo E2-5 plasmid was transfected into 293T cells, the RNA extracted and reverse transcribed. PCR products were run on an agarose gel and visualized with ethidium bromide. No alternative splice products were observed.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
###xml 678 686 <span type="species:ncbi:9606">patients</span>
###xml 869 877 <span type="species:ncbi:9606">patients</span>
All CTCFL exons were sequenced in SRS patients to test the hypothesis that mutations in this gene may be responsible for hypomethylation of ICR1. No missense or nonsense mutations were found. However, five novel SNPs were identified. As one of the novel SNPs (IVS2-66A>C) was predicted to activate a cryptic 3' splice site near exon 3, a minigene splicing assay was used to determine if CTCFL undergoes SNP-dependent alternative splicing. Neither IVS2-66A>C nor alleles of nearby SNPs displayed alternative splicing at the exon 2/3 junction. These results rule out splicing aberrations of CTCFL as a cause of hypomethylation in these patients. Lastly, the exons of CTCFL in SRS patients were screened for duplications/deletions using MLPA and qPCR. No duplications/deletions were observed, strongly suggesting that genetic alterations of CTCFL are not present in these patients.
###end p 32
###begin p 33
###xml 94 97 82 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-AbuAmero1">[1]</xref>
###xml 164 168 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Kobayashi1">[18]</xref>
###xml 169 173 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Schoherr1">[24]</xref>
###xml 404 409 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 543 547 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Jelinic1">[10]</xref>
###xml 702 707 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
###xml 727 735 <span type="species:ncbi:9606">patients</span>
As maternal uniparental disomy of chromosome 7 is observed in approximately10% of SRS patients[1], previous SRS candidate gene studies have focused on chromosome 7 [18]-[24]. To our knowledge, this study is the first candidate gene approach to examine genes involved in the establishment of imprinted DNA methylation at ICR1. Our findings in this cohort of SRS patients do not indicate that mutations in CTCFL are a cause of the hypomethylation epimutation. If CTCFL participates in directing global imprinted gene DNA methylation as proposed [10], a mutation in the gene may lead to either an embryonic lethal or more severe phenotype than SRS. This is but one explanation for the absence of observed CTCFL alterations in SRS patients. Future investigation will clarify the full impact of CTCFL function on the establishment of DNA methylation during development.
###end p 33
###begin p 34
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Hata1">[12]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Kaneda1">[13]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Eggermann1">[25]</xref>
###xml 494 505 494 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo DNA</italic>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
Further investigation may also point to mutations in other genes/proteins participating in the establishment of DNA methylation at imprinted genes as a cause of hypomethylation in these patients. The de novo DNA methyltransferases DNMT3A and DNMT3L have been shown to be essential for normal imprinted DNA methylation [12], [13] and make strong candidates for a mutational screen in SRS patients with hypomethylation of ICR1 [25]. Lastly, a more comprehensive understanding of the mechanism of de novo DNA methylation at imprinted genes may provide novel candidate genes for further study into the cause of the hypomethylation epimutation and SRS.
###end p 34
###begin title 35
Materials and Methods
###end title 35
###begin title 36
Ethics Statement
###end title 36
###begin p 37
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
The study was performed in accordance with the ethics review boards of the University of Zurich, University of Lausanne and the University Hospital of Lausanne (CHUV). Written informed consent for analysis of DNA was obtained from all adult patients and parents of underage patients included in this work.
###end p 37
###begin title 38
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 38
###begin p 39
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 288 291 288 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bartholdi1">[3]</xref>
###xml 418 421 418 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bartholdi1">[3]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Bartholdi1">[3]</xref>
###xml 39 46 <span type="species:ncbi:9606">patient</span>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
The study population consisted of a 36 patient subgroup from a pool of 201 SRS patients diagnosed by clinics in Zurich, Warsaw, Minsk, and Istanbul. These 36 patients were selected for further analysis due to hypomethylation at the IGF2/H19 ICR as determined by methylation-specific MLPA [3]. The 36 patients have SRS severity scores ranging from 8 to 15 (mean, 11.8, 4 undetermined) as ascertained by Bartholdi et al [3]. One hundred unrelated healthy individuals served as controls. Genomic DNA was extracted as previously described [3].
###end p 39
###begin title 40
Sequencing
###end title 40
###begin p 41
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 420 428 420 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006631.s001">Table S1</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Renaud1">[16]</xref>
###xml 608 615 <span type="species:ncbi:9606">patient</span>
CTCFL genomic sequence was downloaded from NCBI Map Viewer and exons were demarcated using the NCBI cDNA sequence NM_080618.2. SNPs were identified using dbSNP and the ABI GeneAssist Genotyping Alignment Map (Applied Biosystems website). This map was then used to design intronic primers to individually amplify exons 2-11 and nested or partially nested primers sequencing primers to directly sequence the PCR products (Table S1). 5'UTR PCR primers were designed to encompass the entire 5'UTR as described by Renaud et al. [16] 100 ng of genomic DNA was used in 50 microl PCR reactions for each exon in each patient using either AmpliTaq Gold (ABI, exons 2-11) or Phusion DNA Polymerase (Finnzymes, 5'UTR). PCR reaction conditions are available upon request. After purification with the QIAquick PCR Purification Kit (Qiagen), PCR products were sequenced and run on an ABI 3130xl DNA Fragment Analyzer. Chromatograms were manually inspected using FinchTV (Geospiza).
###end p 41
###begin title 42
MLPA
###end title 42
###begin p 43
###xml 259 264 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 275 283 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006631.s002">Table S2</xref>
###xml 1363 1371 <span type="species:ncbi:9606">patients</span>
MLPA reactions were performed using the SALSA MLPA kit (MRC-Holland, Amsterdam, Netherlands) according to manufacturer's instructions. Briefly, 100 ng of genomic DNA was denatured for 5 min. at 98degreesC and cooled to 25degreesC. A master mix containing the CTCFL probemix (Table S2), DQ- and DD-control probes (MRC-Holland) and MLPA buffer were added and the mixture was heated briefly (1 min.) to 95degreesC, before annealing the MLPA probes to the genomic DNA at 60degreesC overnight. A mastermix containing Ligase-65 Buffers A+B and Ligase-65 was added to the same tubes at 54degreesC and allowed to ligate for 15 min. followed by a 5 min. incubation at 98degreesC and stored at 4degreesC. 50 microl PCR reactions were performed using 10 microl of MLPA reaction product with SALSA PCR primers (FAM-labeled), enzyme dilution buffer and polymerase using the recommended PCR cycling conditions. The FAM-labeled PCR products were separated on an ABI 3130xl and the size was determined by the addition of ROX-250-labelled size standards (ABI). The MLPA PCR products were visualized with Peakscanner software (ABI) and quality-checked by the presence/absence of DQ- and DD-control fragments. The chromatograms were exported as .fsa files to Coffalyser (MRC-Holland) for statistical analysis. Chromatograms of 7 healthy controls were used to normalize those of SRS patients.
###end p 43
###begin title 44
qPCR
###end title 44
###begin p 45
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 329 337 329 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006631.s003">Table S3</xref>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Genomic DNA from SRS patients and healthy controls was used for quantitative real-time PCR (qPCR) to screen for deletions at exon 8 and 9 of CTCFL. Primers were designed for exons 8 and 9 of CTCFL, exon 7 of TP53 (diploid control) and exon 5 of steryl-sulfatase precursor (STS), an X chromosome gene (haploid control, in males) (Table S3).
###end p 45
###begin p 46
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 294 299 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 315 320 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 336 340 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TP53</italic>
###xml 349 352 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STS</italic>
###xml 421 426 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Power</italic>
This allowed normalization of all reactions to TP53, while facilitating analysis of possible deleted CTCFL exons by comparison to STS reactions in males, which have only one copy of the gene. The concentration for each primer pair was optimized for 10 microl reactions and was used as follows: CTCFL exon 8 200 nM, CTCFL exon 9 400 nM, TP53 200 nM, STS 600 nM. Reactions were performed using 50 ng of genomic DNA with 2X Power SYBR(R) Green PCR Master Mix (ABI), forward and reverse primer mix (5 mM) and water to 10 microl. All qPCR reactions were run on an ABI 7900HT using standard conditions.
###end p 46
###begin title 47
Minigene splicing assay
###end title 47
###begin p 48
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 76 85 76 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Reese1">[26]</xref>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Cartegni1">[27]</xref>
###xml 534 539 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTCFL</italic>
###xml 615 648 615 648 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCGGGATCCAGAGTGTGCTCAGGCGGAAC</named-content>
###xml 687 723 687 723 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CGCACTAGTGTGAGTACCGCCAAACCTGTTAG</named-content>
###xml 765 768 765 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 775 778 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Singh1">[17]</xref>
###xml 1107 1108 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1136 1140 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Chen1">[28]</xref>
###xml 1442 1470 1438 1466 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTGCTGCCGCCGGGCGGTGGCTG</named-content>
###xml 1540 1544 1536 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006631-Singh1">[17]</xref>
###xml 1645 1669 1641 1665 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GTGTGGCCATTAGTATCCAG</named-content>
###xml 1680 1704 1676 1700 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCTGTAGGTTGATCCTCTTG</named-content>
###xml 424 431 <span type="species:ncbi:9606">patient</span>
To analyze possible mis-splicng caused by novel SNPs in CTCFL we first used in silico methods to search for possible splice-altering SNPs. Two online programs, Flybase Splice Site Predictor ()[26] and ESE Finder 3.0 ()[27] were used to analyze splice sites with or without the novel SNP and flanking sequence. To experimentally test for alternative splicing caused by novel SNPs we used a minigene splicing assay. 100 ng of patient or control DNA was used in PCR reactions with Phusion DNA polymerase to amplify the genomic region of CTCFL encompassing exons 2-5 (E2-5) using primers upstream of exon 2 (miniE2-5f: 5'- GCGGGATCCAGAGTGTGCTCAGGCGGAAC) and downstream of exon 5 (miniE2-5r: 5'- CGCACTAGTGTGAGTACCGCCAAACCTGTTAG). The PCR product was then digested with BamHI and SpeI, gel-purified, and cloned into pRHCglo [17]. Individual colonies of DH10 transformed with pRHCglo E2-5 were picked, grown overnight and plasmid DNA was extracted using the QIAprep Spin Miniprep Kit (Qiagen). Plasmid DNA was sequenced to identify transformants of each allele. Next, 5 microg of pRHCglo E2-5 plasmid DNA was CaPO4-tranfected into 293T cells [28]. Cells were grown overnight, the media was changed the next morning and cells were left to grow for a total of 48 hours. Total RNA was extracted using TRI-Reagent (Sigma) and reverse transcription and PCR were performed using the SuperScript III One-Step RT-PCR System (Invitrogen). The primer TNIE4 (5'-AGGTGCTGCCGCCGGGCGGTGGCTG) was used for reverse transcription as described by Singh and Cooper [17]. PCR primers were designed and used to amplify the exon 2/3 boundary to evaluate splicing (splchkf: 5'- GTGTGGCCATTAGTATCCAG; splchkr: 5'- GCTGTAGGTTGATCCTCTTG). PCR products were then analyzed by agarose gel electrophoresis.
###end p 48
###begin title 49
Supporting Information
###end title 49
###begin p 50
Genomic CTCFL PCR and sequencing primers
###end p 50
###begin p 51
(0.06 MB DOC)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
CTCFL MLPA Probes
###end p 53
###begin p 54
(0.04 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
qPCR primers
###end p 56
###begin p 57
(0.03 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
Exon 5 duplication PCR primers
###end p 59
###begin p 60
(0.03 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
We thank Thomas A. Cooper for the kind gift of pRHCglo, as well as Carlo Rivolta and Roland Sahli for helpful discussions.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
The genetic aetiology of Silver-Russell syndrome.
###end article-title 64
###begin article-title 65
Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome.
###end article-title 65
###begin article-title 66
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes.
###end article-title 66
###begin article-title 67
Clinically distinct epigenetic subgroups in Silver-Russell Syndrome: the degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies.
###end article-title 67
###begin article-title 68
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Parental imprinting of the mouse H19 gene.
###end article-title 68
###begin article-title 69
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Parental imprinting of the mouse insulin-like growth factor-II gene.
###end article-title 69
###begin article-title 70
Chromatin insulators: regulatory mechanisms and epigenetic inheritance.
###end article-title 70
###begin article-title 71
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
###end article-title 71
###begin article-title 72
CTCF maintains differential methylation at the Igf2/H19 locus.
###end article-title 72
###begin article-title 73
The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation.
###end article-title 73
###begin article-title 74
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma.
###end article-title 74
###begin article-title 75
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice.
###end article-title 75
###begin article-title 76
Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting.
###end article-title 76
###begin article-title 77
DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction.
###end article-title 77
###begin article-title 78
PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.
###end article-title 78
###begin article-title 79
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.
###end article-title 79
###begin article-title 80
Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing.
###end article-title 80
###begin article-title 81
###xml 67 75 <span type="species:ncbi:9606">patients</span>
No evidence of PEG1/MEST gene mutations in Silver-Russell syndrome patients.
###end article-title 81
###begin article-title 82
No evidence of dup(7)(p11.2p13) in Silver-Russell syndrome.
###end article-title 82
###begin article-title 83
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Searching for genomic variants in the MESTIT1 transcript in Silver-Russell syndrome patients.
###end article-title 83
###begin article-title 84
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Genomic characterisation of C7orf10 in Silver-Russell syndrome patients.
###end article-title 84
###begin article-title 85
Characterization of genomic variants in CSH1 and GH2, two candidate genes for Silver-Russell syndrome in 17q24-q25.
###end article-title 85
###begin article-title 86
No evidence of submicroscopic deletion or segmental uniparental disomy within the candidate regions 7p11.2-p13 and 7q31-qter in a series of non-uniparental disomy Silver-Russell syndrome cases.
###end article-title 86
###begin article-title 87
###xml 87 95 <span type="species:ncbi:9606">patients</span>
No evidence for isolated imprinting mutations in the PEG1/MEST locus in Silver-Russell patients.
###end article-title 87
###begin article-title 88
Growth retardation versus overgrowth: Silver-Russell syndrome is genetically opposite to Beckwith-Wiedemann syndrome.
###end article-title 88
###begin article-title 89
Improved splice site detection in Genie.
###end article-title 89
###begin article-title 90
ESEfinder: a web resource to identify exonic splicing enhancers.
###end article-title 90
###begin article-title 91
High-efficiency transformation of mammalian-cells by plasmid DNA.
###end article-title 91
###begin p 92
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 92
###begin p 93
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by Swiss National Science Foundation grant #3100AO_118432 to P.S. (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 93

